NCT00329693 - Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

May 31, 2008

Conditions

Ovarian Hyperstimulation Syndrome

Interventions

DRUG

Norprolac

Placebo

DRUG

Norprolac

Quinagolide

DRUG

Norprolac

Quinagolide

DRUG

Norprolac

Quinagolide

Trial Locations (7)

IVI Madrid, Santiago de Compostela, 88, Madrid

IVI Murcia, Navegante Macías del Poyo, 5, Edificio Delfín-Barrio La Flota, Murcia

IVI Vigo, Plaza Francisco Fernández del Riego, 7 (Plaza Elíptica), Vigo (Pontevedra)

IVI Sevilla, Avda. República Argentina, 58, Seville

IVI Valencia, Plaza de la Policía Local, 3, Valencia

IVI Bilbao, Paseo Landabarri, 1, Leioa-Bizkaia

IVI Barcelona, Ronda General Mitre, 14, Barcelona